IART (STOCKS)
Integra LifeSciences Holdings
$18.240000
+0.860000 (+4.95%)
Prev close: $17.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stuart M. Essig
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,417.79M
- Employees
- 4,396
- P/E (TTM)
- -192.20
- P/B (TTM)
- 1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
8
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.56 | $0.49 | +0.0669 | +13.57% |
|
Mar 2026 (Q1)
|
$0.54 | $0.41 | +0.1274 | +30.88% |
|
Dec 2025 (Q4)
|
$0.83 | $0.82 | +0.0137 | +1.68% |
|
Sep 2025 (Q3)
|
$0.54 | $0.44 | +0.0963 | +21.70% |
Financial Statements
| Revenues | $1.65B |
| Benefits Costs and Expenses | $1.65B |
| Cost Of Revenue | $783.08M |
| Costs And Expenses | $1.58B |
| Gross Profit | $864.58M |
| Operating Expenses | $799.03M |
| Selling, General, and Administrative Expenses | $688.98M |
| Other Operating Expenses | $110.04M |
| Operating Income/Loss | $65.56M |
| Income/Loss From Continuing Operations After Tax | -$7.24M |
| Income/Loss From Continuing Operations Before Tax | -$181.00K |
| Income Tax Expense/Benefit | $7.06M |
| Income Tax Expense/Benefit, Deferred | -$22.61M |
| Net Income/Loss | -$7.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.09 |
| Basic Average Shares | 153,910,000 |
| Diluted Average Shares | 153,910,000 |
| Assets | $3.56B |
| Current Assets | $1.19B |
| Inventory | $492.01M |
| Prepaid Expenses | $104.34M |
| Other Current Assets | $595.13M |
| Noncurrent Assets | $2.37B |
| Fixed Assets | $446.20M |
| Intangible Assets | $1.08B |
| Other Non-current Assets | $850.26M |
| Liabilities | $2.52B |
| Current Liabilities | $330.88M |
| Wages | $68.18M |
| Other Current Liabilities | $262.70M |
| Noncurrent Liabilities | $2.19B |
| Long-term Debt | $707.19M |
| Other Non-current Liabilities | $1.48B |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.04B |
| Liabilities And Equity | $3.56B |
| Net Cash Flow From Operating Activities | $85.33M |
| Net Cash Flow From Operating Activities, Continuing | $85.33M |
| Net Cash Flow From Investing Activities | -$108.63M |
| Net Cash Flow From Investing Activities, Continuing | -$108.63M |
| Net Cash Flow From Financing Activities | $21.58M |
| Net Cash Flow From Financing Activities, Continuing | $21.58M |
| Exchange Gains/Losses | -$1.78M |
| Net Cash Flow | -$3.50M |
| Net Cash Flow, Continuing | -$1.72M |
| Comprehensive Income/Loss | -$15.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.53M |
| Other Comprehensive Income/Loss | -$11.05M |
| Other Comprehensive Income/Loss Attributable To Parent | -$9.29M |